HealthStream (HSTM) PT Raised to $34 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- US stock futures gain ahead of July inflation data
- Oil prices rise after ship attacks, US-Iran talks deadlock
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
HealthStream (HSTM) PT Raised to $29 at Canaccord Genuity
October 23, 2024 7:19 AM EDTCanaccord Genuity analyst Richard Close raised the price target on HealthStream (NASDAQ: HSTM) to $29.00 (from $28.00) while maintaining a Hold rating.
The analyst comments "HealthStream posted another steady quarter in 3Q. Adj-EBITDA come in ahead of our and Street estimates, though revenue slightly missed. Revenue guidance was lowered $3 million at the midpoint which management attributed to the utilization anomaly of a consumption-based learning product at a large customer discussed last quarter where consumption returned to normalized levels as opposed to the accelerated consumption levels previously expected. With... More
